Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Taysha Gene Therapies (TSHA) Prepaid Assets: 2022-2024

Historic Prepaid Assets for Taysha Gene Therapies (TSHA) over the last 3 years, with Dec 2024 value amounting to $2.6 million.

  • Taysha Gene Therapies' Prepaid Assets fell 36.86% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 36.86%. This contributed to the annual value of $2.6 million for FY2024, which is 23.97% down from last year.
  • As of FY2024, Taysha Gene Therapies' Prepaid Assets stood at $2.6 million, which was down 23.97% from $3.5 million recorded in FY2023.
  • Taysha Gene Therapies' 5-year Prepaid Assets high stood at $8.5 million for FY2022, and its period low was $2.6 million during FY2024.
  • Its 3-year average for Prepaid Assets is $4.9 million, with a median of $3.5 million in 2023.
  • Data for Taysha Gene Therapies' Prepaid Assets shows a maximum YoY crashed of 59.25% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Taysha Gene Therapies' Prepaid Assets stood at $8.5 million in 2022, then slumped by 59.25% to $3.5 million in 2023, then fell by 23.97% to $2.6 million in 2024.